Panbela Therapeutics Inc. (PBLA) Misses Q2 EPS by 147c
Tweet
Share
E-mailGet Alerts PBLA Hot Sheet
Join SI Premium – FREE
Panbela Therapeutics Inc. (OTC: PBLA) reported Q2 EPS of ($1.47).
For earnings history and earnings-related data on Panbela Therapeutics Inc. (PBLA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abu Dhabi's G42 Weighs US Ownership To Safeguard AI Chip Access - Bloomberg
- Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
- UBS Reiterates Buy Rating on Linde (LIN) as Challenges in Helium Are 'Being Managed'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
